Concepedia

Luisa Foltran

LF

28

Publications

1.5K

Citations

17

H-Index

2012

Active since

Affiliations

Istituti di Ricovero e Cura a Carattere Scientifico(Current)

Centro di Riferimento Oncologico

University of Udine

Azienda Ospedaliera Santa Maria Degli Angeli

Ospedale Santa Maria della Misericordia di Udine

Luisa Foltran is an author at Istituti di Ricovero e Cura a Carattere Scientifico specializing in medicine, oncology, and cancer research.

ORCID

Top concepts

Publications per year

2012–2024

28

Publications

28

A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

Jesse J. Swen, Cathelijne H. van der Wouden, Lisanne E. N. Manson et al. · The Lancet · 2023 · 462 citations · Full text

, , +9

Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial

Josep M. Llovet, Masatoshi Kudo, Philippe Merle et al. · The Lancet Oncology · 2023 · 364 citations

, , +10

Dihydropyrimidine dehydrogenase pharmacogenetics for predicting fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA trial in high-risk colon cancer patients

Annamaria Ruzzo, Francesco Graziano, Fabio Galli et al. · British Journal of Cancer · 2017 · 68 citations · Full text

Prognostic Role of <i>KRAS, NRAS, BRAF</i> and <i>PIK3CA</i> Mutations in Advanced Colorectal Cancer

Luisa Foltran, Giovanna De Maglio, Nicoletta Pella et al. · Future Oncology · 2015 · 59 citations

Unplanned presentations of cancer outpatients: a retrospective cohort study

Giuseppe Aprile, Federica Pisa, Alessandro Follador et al. · Supportive Care in Cancer · 2012 · 54 citations

, , +5

Rows per page

1–5 of 28